Immunovant, Inc. IMVT
29.19 USD +0.78 +2.74%
As of Nov 3, 1:51 PM ET
21.43 52-week range 45.42
- YTD
- +14.82%
- 1 year
- +22.74%
- Open
- 29.00
- Prev close
- 28.41
- Mkt cap
- 6.03B
- Vol
- 383.99K
- Avg vol
- 1.37M
- EPS
- -2.82
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 28.42
- High
- 29.48
- Forward P/E
- -10.33
- Beta
- 0.94
- Short ratio
- 10.91
- Inst. own
- 54.76%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 34.56
- 200-d avg
- 32.04
- 1y target
- 48.88
5D chart
Chart tools
Chart is warming up
The five-day price history for IMVT has not been loaded yet. Try again in a moment.
Altman Z-Score
25.90 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -9.0×
P/S 0.0×
P/B 5.3×
P/FCF -11.1×
EV/EBITDA -7.2×
EV/Sales 0.0×
FCF Yield -9.0%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE -59.3%
ROIC -62.5%
ROA -52.8%
Revenue 0.0%
Operating Income -21.6%
EPS (diluted) -1.5%
Free Cash Flow -8.1%
Current Ratio 9.1×
Quick Ratio 9.1×
Debt / Equity 0.0×
Net Debt / EBITDA 1.8×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31
